A new research report from Statler Nagle, LLC concludes that the shift to recombinant bovine somatotropin (rbST)-free milk was an overly quick response to a problem that seemed bigger than it was in reality. Study findings suggest that although only 8 to 12% of consumers were concerned enough about rbST to change purchasing or consumption behaviors, milk-processing companies instead opted … Read More